Business
AIMEI HEALTH TECHNOLOGY CO., LTD RECEIVES NASDAQ NOTICE REGARDING DELAYED QUARTERLY REPORT
New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company
About this update from Aimei Health Technology Co., Ltd
[{"type":"image","alt":"AIMEI HEALTH TECHNOLOGY CO., LTD","displaySize":"","headline":null,"caption":"AIMEI HEALTH TECHNOLOGY CO., LTD","className":"","disableSlideshowImg":false,"size":{"original":{"width":269,"height":119,"url":"https://media.zenfs.com/en/globenewswire.com/9ca3fb402487ebf3e1c9eecab0cc4139"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/v83uBWBqed4s3PBe5j0XeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4Ng--/https://media.zenfs.com/en/globenewswire.com/9ca3fb402487ebf3e1c9eecab0cc4139","width":269,"height":119},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/v83uBWBqed4s3PBe5j0XeQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTE4Ng--/https://media.zenfs.com/en/globenewswire.com/9ca3fb402487ebf3e1c9eecab0cc4139","width":269,"height":119}},"lazy":false},{"type":"text","content":"New York, NY, May 20, 2026 (GLOBE NEWSWIRE) -- Aimei Health Technology Co., Ltd (the “Company”) (Nasdaq: AFJK) today announced that on May 19, 2026, it received a notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, as a result of the Company’s delay in filing its Quarterly Report on Form 10-Q for the period ended March 31, 2026 (the “Quarterly Report”) with the U.S. Securities and Exchange Commission (the “SEC”), the Company is not in compliance with the requirements for continued listing under Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”). The Quarterly Report was due on May 15, 2026.","length":670,"tagName":"p"},{"type":"text","content":"The Notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. However, if the Company fails to timely regain compliance with the Listing Rule, the Company’s securities will be subject to delisting from Nasdaq.","length":247,"tagName":"p"},{"type":"text","content":"Under Nasdaq rules, the Company has 60 calendar days from the date of the Notice to either file the Quarterly Report or submit a plan to Nasdaq to regain compliance with Nasdaq’s listing rules. If a plan is submitted and accepted, the Company may be granted up to 180 calendar days from the Quarterly Report’s due date to regain compliance. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Nasdaq hearings panel.","length":476,"tagName":"p"},{"type":"text","content":"The Company is working diligently to...